The growth arrest-specific 6 (Gas6) gene polymorphism c.834+7G>A is associated with type 2 diabetes

Diabetes Research and Clinical Practice

Volumn 95, Issue 2, 2012, Pages 201-206

  Lee, Chien Hsing ^a   Chu, Nain Feng ^b,c   Shieh, Yi Shing ^a,b   Hung, Yi Jen ^a  

^a TRI SERVICE GENERAL HOSPITAL   (Taiwan)

^b NATIONAL DEFENSE MEDICAL CENTER   (Taiwan)

^c TAIPEI MEDICAL UNIVERSITY   (Taiwan)

Author keywords

Diabetes; Growth arrest specific 6 gene; Polymorphism

Indexed keywords

GLUCOSE; GROWTH ARREST SPECIFIC PROTEIN 6;

ADULT; ARTICLE; CONTROLLED STUDY; FEMALE; GENE; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC RISK; GENOTYPE; GLUCOSE TOLERANCE; GROWTH ARREST SPECIFIC 6 GENE; GROWTH ARREST SPECIFIC PROTEIN 6 BLOOD LEVEL; HUMAN; IMPAIRED GLUCOSE TOLERANCE; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PROTEIN BLOOD LEVEL;

ADULT; AGED; ANALYSIS OF VARIANCE; DIABETES MELLITUS, TYPE 2; DIABETIC ANGIOPATHIES; DIABETIC NEPHROPATHIES; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; GLUCOSE INTOLERANCE; GLUCOSE TOLERANCE TEST; HUMANS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; TAIWAN;

EID: 84856360813     PISSN: 01688227     EISSN: 18728227     Source Type: Journal    
DOI: 10.1016/j.diabres.2011.09.013     Document Type: Article

References (18)

1. Bellido-Martin L., de Frutos P.G. Vitamin K-dependent actions of Gas6. Vitam Horm 2008, 78:185-209.
2. Hafizi S., Dahlback B. Gas6 protein S. Vitamin K-dependent ligands for the Axl receptor tyrosine kinase subfamily. FEBS J 2006, 273:5231-5244.
3. Bellosta P., Zhang Q., Goff S.P., Basilico C. Signaling through the ARK tyrosine kinase receptor protects from apoptosis in the absence of growth stimulation. Oncogene 1997, 15:2387-2397.
4. Nagata K., Ohashi K., Nakano T., Arita H., Zong C., Hanafusa H., et al. Identification of the product of growth arrest-specific gene 6 as a common ligand for Axl, Sky, and Mer receptor tyrosine kinases. J Biol Chem 1996, 271:30022-30027.
5. Collett G., Wood A., Alexander M.Y., Varnum B.C., Boot-Handford R.P., Ohanian V., et al. Receptor tyrosine kinase Axl modulates the osteogenic differentiation of pericytes. Circ Res 2003, 92:1123-1129.
6. Godowski P.J., Mark M.R., Chen J., Sadick M.D., Raab H., Hammonds R.G. Reevaluation of the roles of protein S and Gas6 as ligands for the receptor tyrosine kinase Rse/Tyro 3. Cell 1995, 82:355-358.
7. Linger R.M., Keating A.K., Earp H.S., Graham D.K. TAM receptor tyrosine kinases: biologic functions, signaling, and potential therapeutic targeting in human cancer. Adv Cancer Res 2008, 100:35-83.
8. Nagai K., Arai H., Yanagita M., Matsubara T., Kanamori H., Nakano T., et al. Growth arrest-specific gene 6 is involved in glomerular hypertrophy in the early stage of diabetic nephropathy. J Biol Chem 2003, 278:18229-18234.
9. Cavet M.E., Smolock E.M., Ozturk O.H., World C., Pang J., Konishi A., et al. Gas6-axl receptor signaling is regulated by glucose in vascular smooth muscle cells. Arterioscler Thromb Vasc Biol 2008, 28:886-891.
10. Hung Y.J., Lee C.H., Chu N.F., Shieh Y.S. Plasma protein growth arrest-specific 6 levels are associated with altered glucose tolerance, inflammation, and endothelial dysfunction. Diabetes Care 2010, 33:1840-1844.
11. Manfioletti G., Brancolini C., Avanzi G., Schneider C. The protein encoded by a growth arrest-specific gene (gas6) is a new member of the vitamin K-dependent proteins related to protein S, a negative coregulator in the blood coagulation cascade. Mol Cell Biol 1993, 13:4976-4985.
12. Munoz X., Sumoy L., Ramirez-Lorca R., Villar J., de Frutos P.G., Sala N. Human vitamin K-dependent GAS6: gene structure, allelic variation, and association with stroke. Hum Mutat 2004, 23:506-512.
13. Munoz X., Obach V., Hurtado B., de Frutos P.G., Chamorro A., Sala N. Association of specific haplotypes of GAS6 gene with stroke. Thromb Haemost 2007, 98:406-412.
14. Jiang L., Liu C.Y., Yang Q.F., Wang P., Zhang W. Plasma level of growth arrest-specific 6 (GAS6) protein and genetic variations in the GAS6 gene in patients with acute coronary syndrome. Am J Clin Pathol 2009, 131:738-743.
15. Balogh I., Hafizi S., Stenhoff J., Hansson K., Dahlback B. Analysis of Gas6 in human platelets and plasma. Arterioscler Thromb Vasc Biol 2005, 25:1280-1286.
16. Burnier L., Borgel D., Ngelillo-Scherrer A., Fontana P. Plasma levels of the growth arrest-specific gene 6 product (Gas6) and antiplatelet drug responsiveness in healthy subjects. J Thromb Haemost 2006, 4:2283-2284.
17. Borgel D., Clauser S., Bornstain C., Bieche I., Bissery A., Remones V., et al. Elevated growth-arrest-specific protein 6 plasma levels in patients with severe sepsis. Crit Care Med 2006, 34:219-222.
18. Gibot S., Massin F., Cravoisy A., Dupays R., Barraud D., Nace L., et al. Growth arrest-specific protein 6 plasma concentrations during septic shock. Crit Care 2007, 11:R8.